Moreover, the activation of TGF-β impairs the competitive advantage of normal hematopoietic stem cells, which actually contributes to the selection of early-stage myelodysplastic syndrome-genic clones [174, 175]. The gene discussed is TGFB1; the disease is myelodysplastic syndrome.